Document Detail


Myc induced miR-144/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562.
MedLine Citation:
PMID:  22842456     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Imatinib resistance remains the big hurdle for CML therapy. Previous study reveals that c-myc is important for bcr-abl CML cell proliferation, while its role in imatinib resistance is largely unknown. In this study, we first found that c-myc expression is upregulated in imatinib resistant K562R cells, which in turn enhances the expression of miR-144/451. Knockdown of c-myc or restoration of miR-144/451 in the K562R cells sensitizes K562R cells to imatinib therapy. Our study here reveals an regulatory pathway between myc and miR-144/451 and highlights that targeting either myc or miR-144/451 might be valuable for eliminating the imatinib resistant CML cells.
Authors:
Li Liu; Sitao Wang; Renan Chen; Yanlan Wu; Bei Zhang; Siyong Huang; Jingyi Zhang; Fang Xiao; Meng Wang; Yingmin Liang
Related Documents :
18676656 - 3'-phosphoinositides regulate the coordination of speed and accuracy during chemotaxis.
11121786 - Pattern formation: fruiting body morphogenesis in myxococcus xanthus.
22580986 - Development and characterization of a preclinical ovarian carcinoma model to investigat...
22640016 - Cell-cell communication in the resistance vasculature: the past, present and future.
22503056 - Expression and role of hmga1 in renal cell carcinoma.
1791206 - Oncocytic metaplasia of the nasopharynx or extra-parotid warthin's tumour?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-26
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  -     ISSN:  1090-2104     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Affiliation:
Department of Hematology, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  YM155 induces disruption of the ILF3/p54(nrb) complex, which is required for survivin expression.
Next Document:  Molecular basis for the Kallmann syndrome-linked fibroblast growth factor receptor mutation.